Journal profile
Medicine in Omics
ISSN 2590-1249 · Elsevier · Netherlands
Medicine in Omics: fully open access; APC about USD 2,230; review about 284 days (submission to acceptance, publisher); 11 articles in 2025.
Scope
Aims, scope and focus
Medicine in Omics is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, Bioinformatics and Genomic Networks and Computational Drug Discovery Methods, together about 26.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Medicine in Omics is a peer-reviewed open access journal. The journal publishes human health related original omics research, including genomics, proteomics, epigenomics metabolomics, lipidomics, peptidomics, metagenomics, microbiomics, pharmacogenomics, toxicogenomics etc., with the focus on disease etiology, prevention, diagnosis, treatment and therapy, prognosis and monitoring.Article types accepted include, but are not limited to, original research articles, reviews, case reports, short communications and editorials.
From the journal's Aims & Scope
Editorial board by country: 8 in mainland China (about 36%); most named Mainland China 8, United States 4, Belgium 3, Portugal 2, Japan 1 (22 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology11.5%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology8.1%
- Computational Drug Discovery MethodsComputer Science6.9%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.8%
- Tuberculosis Research and EpidemiologyMedicine4.6%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.6%
- Gene expression and cancer classificationBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 8OpenAlex ·
- i10-index
- 8OpenAlex ·
- 2-year mean citedness
- 3.86OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 57 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 10 | 10 | 62 |
| 2025 | 11 | 11 | 98 |
| 2024 | 8 | 8 | 58 |
| 2023 | 12 | 12 | 25 |
| 2022 | 4 | 4 | 14 |
| 2021 | 8 | 8 | 11 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
284 dayssubmission to acceptance · community reports about 17 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 17 weeksLetPub ·
- Submission to first decision
- 11 daysPublisher website ·
- First decision after review
- 95 daysPublisher website ·
- Submission to acceptance
- 284 daysPublisher website ·
- Acceptance to publication
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 38 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,230 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,120 / EUR 1,980 / GBP 1,700 / JPY 262,940 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 2,230 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2590-1249
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Medicine in Omics
How long does peer review take at Medicine in Omics?
The publisher reports about 284 days (submission to acceptance); authors report an average review time of about 17 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Medicine in Omics based?
Of the 22 board members whose country the journal's board page names, 8 (about 36%) are in mainland China; the countries named most often are Mainland China (8), United States (4) and Belgium (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Medicine in Omics?
According to LetPub and DOAJ records, Medicine in Omics is indexed in DOAJ.
Is Medicine in Omics open access, and what is the APC?
Medicine in Omics is a fully open-access journal. APC about USD 2,230.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .